124 related articles for article (PubMed ID: 2979692)
21. Hemodynamic effects of glucagon in portal hypertension.
Silva G; Navasa M; Bosch J; Chesta J; Pilar Pizcueta M; Casamitjana R; Rivera F; Rodés J
Hepatology; 1990 Apr; 11(4):668-73. PubMed ID: 2328958
[TBL] [Abstract][Full Text] [Related]
22. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
23. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
24. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension.
Vlavianos P; Mac Mathuna P; Williams R; Westaby D
Clin Sci (Lond); 1999 May; 96(5):475-81. PubMed ID: 10209079
[TBL] [Abstract][Full Text] [Related]
25. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
26. Continuous blood pressure monitoring in cirrhosis. Relations to splanchnic and systemic haemodynamics.
Møller S; Christensen E; Henriksen JH
J Hepatol; 1997 Aug; 27(2):284-94. PubMed ID: 9288602
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of verapamil, tiapamil, diltiazem and nifedipine on systemic and splanchnic hemodynamics in man.
Gasic S; Eichler HG; Korn A
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):498-503. PubMed ID: 3679621
[TBL] [Abstract][Full Text] [Related]
28. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
[TBL] [Abstract][Full Text] [Related]
29. [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
Valla D; Lee SS; Moreau R; Hadengue A; Sayegh R; Lebrec D
Gastroenterol Clin Biol; 1985 Dec; 9(12):877-80. PubMed ID: 3830801
[TBL] [Abstract][Full Text] [Related]
30. Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
Ruiz del Arbol L; García-Pagán JC; Feu F; Pizcueta MP; Bosch J; Rodés J
J Hepatol; 1991 Sep; 13(2):179-86. PubMed ID: 1744422
[TBL] [Abstract][Full Text] [Related]
31. Lack of effect of indomethacin on systemic and splanchnic haemodynamics in portal hypertensive rats.
Blanchart A; Hernando N; Fernández-Muñoz D; Hernando L; López-Novoa JM
Clin Sci (Lond); 1985 May; 68(5):605-7. PubMed ID: 3884241
[TBL] [Abstract][Full Text] [Related]
32. Acute systemic and splanchnic haemodynamic effects of L-carnitine in patients with cirrhosis.
Pugliese D; Sabbà C; Ettorre G; Berardi E; Antonica G; Godi L; Palasciano G; Lee SS; Albano O
Drugs Exp Clin Res; 1992; 18(4):147-53. PubMed ID: 1451645
[TBL] [Abstract][Full Text] [Related]
33. Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis.
Møller S; Becker U; Schifter S; Abrahamsen J; Henriksen JH
J Hepatol; 1996 Sep; 25(3):316-28. PubMed ID: 8895011
[TBL] [Abstract][Full Text] [Related]
34. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension.
Kawanaka H; Akahoshi T; Kinjo N; Iguchi T; Ninomiya M; Yamashita YI; Ikegami T; Yoshizumi T; Shirabe K; Maehara Y
Br J Surg; 2014 Nov; 101(12):1585-93. PubMed ID: 25200126
[TBL] [Abstract][Full Text] [Related]
35. Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Chen CF; Hong CY
J Gastroenterol Hepatol; 1997 Aug; 12(8):585-9. PubMed ID: 9304511
[TBL] [Abstract][Full Text] [Related]
36. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Croquet V; Moal F; Veal N; Wang J; Oberti F; Roux J; Vuillemin E; Gallois Y; Douay O; Chappard D; Calès P
J Hepatol; 2002 Dec; 37(6):773-80. PubMed ID: 12445418
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.
Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
Hepatology; 1991 Jan; 13(1):124-8. PubMed ID: 1899080
[TBL] [Abstract][Full Text] [Related]
39. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
[TBL] [Abstract][Full Text] [Related]
40. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H
Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
